Skip to main content

Advertisement

Log in

PEGylated Lipova E120 liposomes loaded with celecoxib: in-vitro characterization and enhanced in-vivo anti-inflammatory effects in rat models

  • Published:
Journal of Biosciences Aims and scope Submit manuscript

Abstract

The goal of the current investigation was to prepare PEGylated Lipova E120 liposomes loaded with celecoxib for the effective treatment of rheumatoid arthritis (RA). PEGylated liposomes were prepared and were characterized using techniques such as particle size distribution, polydispersity index (PDI), zeta potential, encapsulation efficiency and in-vitro release, in-vivo and stability studies. The morphological study was characterized by scanning electron microscopy and transmission electron microscopy. To determine the interaction between drug and polymer Fourier transform infrared, Raman, thermogravimetric analysis and differential scanning calorimetry studies were performed. Results show that formulation F6 was optimized with a particle size of 92.12 ± 1.7 nm, a PDI of 0.278 ± 0.22, a zeta potential of − 40.8 ± 1.7 mV with a maximum encapsulation of 96.6 ± 0.05% of drug in the PEGylated liposomes. The optimized formulation shows a maximum release of drug i.e. 94.45 ± 1.13% in 72 h. Tail immersion assay shows that the optimized formulation F6 significantly increases the reaction time and carrageenan-induced assay shows that the optimized formulation inhibits the increase in paw edema thus providing a pain relief treatment in RA. These results suggest that the PEGylated liposomes provide a sustained release of celecoxib and helps in effective treatment of RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Ahlmen M, Svensson B, Albertsson K, Forslind K and Hafstrom I 2010 Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage. Ann. Rheum. Dis. 69 230–233

    Article  CAS  Google Scholar 

  • Alavi SE, Esfahani MKM, Ghassemi S, Akbarzadeh A and Hassanshahi G 2014 In vitro evaluation of the efficacy of liposomal and Pegylated liposomal hydroxyurea. Indian J. Clin. Biochem. 29 84–88

    Article  CAS  Google Scholar 

  • Atyabi F, Farkhondehfai A, Esmaeil F and Dinarvand R 2009 Preparation of PEGylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice. Acta Pharm. 59 133–144

    Article  CAS  Google Scholar 

  • Begum YM, Abbulu K and Sudhakar M 2012 Celecoxib loaded liposome: Development, characterization and in vitro evaluation. Int. J. Pharm. Sci. Res. 3 154–161

    Google Scholar 

  • Betageri GV and Parsons DL 1992 Drug encapsulation and release from multilamellar and unilamellar liposomes. Int. J. Pharm. 81 235–241

    Article  CAS  Google Scholar 

  • Bhalerao SS and Harshal AR 2003 Preparation, optimization, characterization and stability studies of salicyclic acid liposomes. Drug Dev. Ind. Pharm. 29 457–467

    Article  Google Scholar 

  • Cheow WS, Chang MW and Hadinoto K 2011 The roles of lipid in anti-biofilm efficacy of lipid–polymer hybrid nanoparticles encapsulating antibiotics. Colloids Surf., A 389 158–165

    Article  CAS  Google Scholar 

  • Dave V, Sharma S, Yadav RB and Agarwal U 2017a Herbal liposome for the topical delivery of ketoconazole for the effective treatment of seborrheic dermatitis. Appl. Nanosci. 7 973–987

    Article  CAS  Google Scholar 

  • Dave V, Yadav RB, Kushwaha K, Yadav S, Sharma S and Agrawal U 2017b Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system. Bioact. Mater. 2 269–280

    Article  Google Scholar 

  • Er Y, Barnes TJ, Fornasiero D and Fornasiero CA 2009 The encapsulation and release of guanosine from PEGylated liposomes. J. Liposome Res. 19 29–36

    Article  CAS  Google Scholar 

  • Gibofsky A 2012 Overview of epidemiology, pathophysiology and diagnosis of rheumatoid arthritis. Am. J. Manag. Care 18 295–302

    Google Scholar 

  • Goldenberg MM 1999 Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. Clin. Ther. 21 1497–1513

    Article  CAS  Google Scholar 

  • Jain NK and Kulkarni SK 1999 Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats. J. Ethnopharmacol. 68 251–259

    Article  CAS  Google Scholar 

  • Kahlenberg JM and Fox DA 2011 Advances in the medical treatment of rheumatoid arthritis. Hand Clin. 27 11–20

    Article  Google Scholar 

  • Kaiser N, Kimpfler A, Massing U, Burger AM, Fiebig HH, Brandl M and Schubert R 2003 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: Entrapment and release properties. Int. J. Pharm. 256 123–131

    Article  CAS  Google Scholar 

  • Li J, Wang X, Zhang T, Wang C, Huang Z, Luo X and Deng Y 2015 A review on phospholipids and their main applications in drug delivery systems. Asian J. Pharm. Sci. 10 81–98

    Article  CAS  Google Scholar 

  • McCormack PL 2011 Celecoxib: A review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and anklosing spondylitis. Drugs 71 2457–2489

    Article  CAS  Google Scholar 

  • Naveed S, Sultana N and Arayne MS 2014 In vivo interaction studies of lisinopril with flurbiprofen and ibuprofen on carrageenan induced inflammation. J. Bioanal. Biomed. 6 1–4

    Google Scholar 

  • Panwar P, Pandey B, Lakhera PC and Singh KP 2010 Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int. J. Nanomed. 5 101–108

    CAS  Google Scholar 

  • Rathode S and Deshpande SG 2010 Design and evaluation of liposomal formulation of Pilocarpine nitrate. Indian J. Pharm. Sci. 72 155–160

    Article  Google Scholar 

  • Re F, Cambianica I, Zona C, Sesana S, Gregori M, Rigolio R, La Ferla B, Nicotra F, Forloni G, Cagnotto A, Salmona M, Masserini M and Sancini G 2011 Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model. Nanomed. Nanotechnol. Biol. Med. 7 551–559

    Article  CAS  Google Scholar 

  • Rengel RG, Barišić K, Pavelić Ž, Grubisic TZ, Cepelak I and Filipovic-Grcic J 2002 High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes. Eur. J. Pharm. Sci. 5 441–448

    Article  Google Scholar 

  • Sant VP and Nagarsenker MS 2011 Synthesis of monomethoxy polyethylene glycol-cholesteryl ester and effect of its incorporation in liposomes. AAPS PharmSciTech 12 1056–1063

    Article  CAS  Google Scholar 

  • Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK and Hua S 2015 Advances and challenges of liposome assisted drug delivery. Front. Pharmacol. 6 286

    Article  Google Scholar 

  • Sharma P, Pant S, Rai S, Yadav RB and Dave V 2017 Green synthesis and characterization of silver nanoparticles by Allium cepa L. to produce silver nano‐coated fabric and their antimicrobial evaluation. Appl. Orgnomet. Chem. 32 1–13

    Google Scholar 

  • Shavi GV, Reddy MS, Raghavendra R, Nayak UY, Kumar AR, Deshpande PB, Udupa N, Behl G, Dave V and Kushwaha K 2016 PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation. J. Liposome Res. 26 28–46

    Article  CAS  Google Scholar 

  • Siebert S, Lyall DM, Mackay DF, Porter D, McInnes IB, Sattar N and Pell JP 2016 Characteristics of rheumatoid arthritis and its association with major comorbid conditions: cross-sectional study of 502 649 UK Biobank participants. RMD Open 2 1–10

    Article  Google Scholar 

  • Sofidiyaa MO, Imeha E, Ezeania C, Aigbeb FR and Akindele AJ 2014 Antinociceptive and anti-inflammatory activities of ethanolic extract of Alafia barteri. Rev. Bras. Farmacogn. 24 348–354

    Article  Google Scholar 

  • Wang X, Song Y, Su Y, Tian Q, Li B, Quan J and Deng Y 2016 Are PEGylated liposomes better than conventional liposomes? A special case for vincristine. Drug Delivery 23 1092–1100

    CAS  PubMed  Google Scholar 

  • Yalcin TE, Ilbasmis-Tamer S, Ibisoglu B, Özdemir A, Ark M and Takka S 2017 Gemcitabine hydrochloride-loaded liposomes and nanoparticles: Comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity. Pharm. Dev. Technol. 23 76–86

    Article  Google Scholar 

Download references

Acknowledgements

The authors acknowledge VAV Life Sciences Pvt Ltd, Mumbai, Maharashtra for providing a gift sample of polymer and their generous support throughout the research work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vivek Dave.

Additional information

Communicated by BJ Rao.

Corresponding editor: BJ Rao

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dave, V., Gupta, A., Singh, P. et al. PEGylated Lipova E120 liposomes loaded with celecoxib: in-vitro characterization and enhanced in-vivo anti-inflammatory effects in rat models. J Biosci 44, 94 (2019). https://doi.org/10.1007/s12038-019-9919-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12038-019-9919-x

Keywords

Navigation